drugset / Trial / NCT01490905

A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain

NCT01490905

Phase 4 Completed 127 enrolled Targeted Medical Pharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This research protocol will compare Theramine to a non-steroidal anti-inflammatory drug (NSAID) in the treatment of chronic back pain. The study will examine the efficacy and tolerability of Theramine alone in patients with chronic back pain in comparison to the NSAID, Ibuprofen, and the co-administration of Ibuprofen with Theramine.

Timeline

Start
2010-09
Primary completion
2011-02
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 400 mg
Subject Theramine Other / unclassified 2 unknown

Indications